» Articles » PMID: 38158734

Mitochondrial Fusion-fission Dynamics and Its Involvement in Colorectal Cancer

Overview
Journal Mol Oncol
Date 2023 Dec 30
PMID 38158734
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence and mortality rates of colorectal cancer have elevated its status as a significant public health concern. Recent research has elucidated the crucial role of mitochondrial fusion-fission dynamics in the initiation and progression of colorectal cancer. Elevated mitochondrial fission or fusion activity can contribute to the metabolic reprogramming of tumor cells, thereby activating oncogenic pathways that drive cell proliferation, invasion, migration, and drug resistance. Nevertheless, excessive mitochondrial fission can induce apoptosis, whereas moderate mitochondrial fusion can protect cells from oxidative stress. This imbalance in mitochondrial dynamics can exert dual roles as both promoters and inhibitors of colorectal cancer progression. This review provides an in-depth analysis of the fusion-fission dynamics and the underlying pathological mechanisms in colorectal cancer cells. Additionally, it offers partial insights into the mitochondrial kinetics in colorectal cancer-associated cells, such as immune and endothelial cells. This review is aimed at identifying key molecular events involved in colorectal cancer progression and highlighting the potential of mitochondrial dynamic proteins as emerging targets for pharmacological intervention.

Citing Articles

PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma.

Tian R, Song H, Li J, Yuan T, Liu J, Wang Y Cancer Biol Ther. 2025; 26(1):2477365.

PMID: 40065703 PMC: 11901378. DOI: 10.1080/15384047.2025.2477365.


Impact of celastrol on mitochondrial dynamics and proliferation in glioblastoma.

Liang L, Lv W, Cheng G, Gao M, Sun J, Liu N BMC Cancer. 2025; 25(1):412.

PMID: 40050778 PMC: 11887396. DOI: 10.1186/s12885-025-13733-9.


Tumor energy metabolism: implications for therapeutic targets.

Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q Mol Biomed. 2024; 5(1):63.

PMID: 39609317 PMC: 11604893. DOI: 10.1186/s43556-024-00229-4.


LRP1B associated with immune cell infiltration influenced the efficacy of immunotherapy in colorectal cancer patients.

Weng W, He S, Zhang G, Zhou X, Li K, Lai J Clinics (Sao Paulo). 2024; 79:100516.

PMID: 39532036 PMC: 11599987. DOI: 10.1016/j.clinsp.2024.100516.


A Review of Advances in Mitochondrial Research in Cancer.

Li Z, Zhang W, Guo S, Qi G, Huang J, Gao J Cancer Control. 2024; 31:10732748241299072.

PMID: 39487853 PMC: 11531673. DOI: 10.1177/10732748241299072.

References
1.
Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S . Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission. Mol Oncol. 2020; 14(12):3169-3183. PMC: 7718948. DOI: 10.1002/1878-0261.12825. View

2.
Nagashima S, Tabara L, Tilokani L, Paupe V, Anand H, Pogson J . Golgi-derived PI4P-containing vesicles drive late steps of mitochondrial division. Science. 2020; 367(6484):1366-1371. DOI: 10.1126/science.aax6089. View

3.
Xie Y, Chen R, Yan L, Jia Z, Liang G, Wang Q . Transcription factor HOXC10 activates the expression of MTFR2 to regulate the proliferation, invasion and migration of colorectal cancer cells. Mol Med Rep. 2021; 24(5). PMC: 8456344. DOI: 10.3892/mmr.2021.12437. View

4.
Cui L, Liu P . Two Types of Contact Between Lipid Droplets and Mitochondria. Front Cell Dev Biol. 2021; 8:618322. PMC: 7769837. DOI: 10.3389/fcell.2020.618322. View

5.
He J, Shangguan X, Zhou W, Cao Y, Zheng Q, Tu J . Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat Commun. 2021; 12(1):4371. PMC: 8285428. DOI: 10.1038/s41467-021-24619-2. View